ICON's goal is to provide exceptional and innovative services to fulfill our clients’ drug development requirements. These services, which include clinical research, biometrics, data management, interactive technologies, laboratory, imaging, clinical pharmacology, resourcing and consulting services, are offered through the expertise of our six global divisions:
We have the operational flexibility and scalability to provide development services on a stand-alone basis or as part of an integrated full-service solution. We are one of a small
group of organisations with the capability and expertise to conduct clinical trials and development projects on a local or global basis.
ICON works with over 350 leading pharmaceutical, biotechnology and medical device companies from 79 offices in 38 countries around the world. We have successfully managed multi-study projects across diverse cultures and regulatory regimes in over 60 countries. We also foster alliances with key local players to provide country specific
knowledge and expertise where appropriate.
Key services include:
Available separately or as part of our comprehensive ‘full-service’ clinical program, Phase II-IIIb Clinical Research services cover a wide range of activities, including: